Related Experiment Video
Updated: May 28, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Aggressive approach and outcome in patients presenting atrial fibrillation and hypertension
Alberto Conti1, Erica Canuti, Yuri Mariannini
1Emergency Medicine, Department of Medical and Surgical Critical Care, University of Florence and Careggi University Hospital, Florence, Italy. aaaconti@hotmail.com
Insights
An aggressive treatment approach for atrial fibrillation (AF) and hypertension improved rhythm control and significantly reduced hospital admissions by 60%. Early intervention for AF lasting less than 48 hours yielded the best outcomes.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Atrial fibrillation (AF) and hypertension are common cardiovascular conditions.
- Effective management of AF, particularly in hypertensive patients, is crucial for improving patient outcomes.
- Rhythm control and reducing hospital admissions are key goals in AF management.
Purpose of the Study:
- To evaluate the effectiveness of an aggressive pharmacological and electrical approach in patients with atrial fibrillation and hypertension.
- To compare rhythm conversion rates and hospital admission reductions between standard and aggressive treatment strategies.
- To identify predictors of successful rhythm conversion and hospitalization in this patient cohort.
Main Methods:
- A comparative study involving 1739 hypertensive patients with AF, divided into standard (n=591) and aggressive (n=1148) treatment groups.
- The aggressive group received enhanced pharmacological and electrical interventions.
- Primary endpoint was rhythm conversion; secondary endpoints included conversion modalities and admission rates.
Main Results:
- The aggressive approach significantly improved overall rhythm conversion rates from 55% to 62% (p=0.018).
- In patients with AF duration less than 48 hours, rhythm conversion was achieved in 89%, with a preference for class 1C antiarrhythmic drugs.
- Hospital admissions were reduced by 60%, with 29% of patients in the aggressive group requiring admission versus 50% in the standard group (p<0.001).
Conclusions:
- An aggressive treatment strategy for AF in hypertensive patients significantly enhances rhythm conversion.
- Early intervention in AF (duration < 48 hours) with class 1C antiarrhythmics is highly effective for achieving sinus rhythm.
- This aggressive approach leads to a substantial reduction in hospital admissions, improving overall patient management.
Aim:
Aggressive approach in patients presenting atrial fibrillation (AF) and hypertension could result in improving rhythm control and reducing admission.
Methods:
Out of 3475 patients presenting AF, those with hypertension (n=1739, 52%) underwent standard (n=591, group 1, years 2004-2005) or aggressive pharmacological and electrical approach (n=1148, group 2, years 2006-2009). Overall, in 1071 patients AF duration was less than 48 h. Primary endpoint was rhythm conversion; secondary endpoints were modalities of rhythm conversion and reduction of admissions.
Results:
At univariate and multivariate analyses, AF lasting less than 48 h, absence of comorbidities and younger age were independent predictors of sinus rhythm; conversely, lack of sinus rhythm, older age, AF lasting more than 48 h and comorbidities were independent predictors of hospitalization. Overall, 55% of patients achieved sinus rhythm in group 1 versus 62% in group 2 (p=0.018). Interestingly, in patients with AF lasting less than 48 h, 89% achieved sinus rhythm, more likely by class 1C than by class III antiarrhythmic drugs (p<0.001). Overall reduction of admission accounts for 60%; 50% of patients need admission in group 1 versus 29% in group 2 (p<0.001).
Conclusions:
Aggressive pharmacological and electrical approach in patients presenting AF and hypertension significantly improved rhythm conversion overall up to 62%. Patients with AF lasting less than 48 h eventually achieved sinus rhythm up to 89%, mostly by class IC antiarrhythmic drugs. Admissions eventually reduced up to 60%.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management
Dysrhythmias VI: Management of Dysrhythmias
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hypertension IV: Drug Therapy and Lifestyle Modifications
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
